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Copper-containing benzylamine oxidase with a specific activity of 200 units was isolated from bovine brain 
microvessels. It was shown that the content of the enzyme in microvessels was significantly higher as 
compared with large blood vessels uch as heart aorta. Some physico-chemical properties of the enzyme 
were determined. The enzyme was inhibited by high concentrations of the substrate as well as thiol reagents 
and ,&-aminopropionitrile fumarate. On the basis of EPR and optical spectra of the enzyme its copper was 
considered to be ‘non-blue’ type. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Two copper-containing enzymes have so far 
been isolated from large blood vessels uch as aor- 
ta. One is the soluble enzyme, benzylamine oxidase 
[ 11, and the other lysyl oxidase which is solubilized 
using urea solutions or nonionic detergents [2-41. 
These enzymes play a central role in regulation of 
vessel elasticity [5,6]. Recently, we were able to ob- 
tain benzylamine oxidase in a highly purified state 
from bovine aorta and some optical and magnetic 
properties of the enzyme were studied [7]. It 
should be noted, however, that there are many dif- 
ferences in functions of large and small blood 
vessels [S]. Thus, the role of microvessels as 
regulators of blood-tissue barriers is well known, 
whereas large vessels lack this property [9]. 
Therefore, it was of importance to compare pro- 
perties of these copper-containing enzymes 
isolated from large and small blood vessels. 
However, to date no data on copper-containing 
proteins of microvessels have been published. 
Bearing this in mind the main aim of this study was 
to determine whether brain microvessels contain 
any soluble copper-containing protein and, if this 
is the case, to test its enzymatic properties and to 
compare it with copper-containing enzymes of the 
aorta1 tissue. 
Microvessels from grey matter of bovine brain 
hemispheres were prepared using filtration of the 
homogenate through nylon sieves and floating pro- 
perties of microvessels as described in [lo]. In 
typical experiments 1 kg portions of grey matter 
were used as a starting material from which about 
1 g wet weight of microvessels was obtained. The 
purity of the vessel preparation was tested by light 
microscopy. 
Benzylamine oxidase activity was followed spec- 
trophotometrically as in [ 111. The reaction mixture 
was in 0.04 M phosphate buffer, pH 7.7. One unit 
of activity was defined as the amount of the en- 
zyme that catalyzed at 20°C an increase in absor- 
bance at 250 nm of 0.001 per min. The specific ac- 
tivity of the enzyme was expressed as units per mg 
of protein as determined in [I21 with bovine serum 
albumin as standard. Copper content in the en- 
zyme preparation was determined chemically as in 
[13] as well as by the double integration technique 
of the EPR spectrum of the preparation. The con- 
tent of thiol groups in the enzyme was assayed as 
in [14]. 
The Mr was evaluated by gel filtration through 
Sepharose 4B and Sephadex G-200 (superfine) us- 
ing for calibration bovine serum albumin (67000), 
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ceruloplasmin (140000), catalase (220000), 
dopamine-,&hydroxylase (300000), ferritin 
(500000) and Blue Dextran (2000000). 
Optical spectra were obtained at 20°C in lo-mm 
cells on a Beckman Acta M-IV spectrophotometer. 
EPR spectra were recorded at 77 K using a Varian 
E-104 instrument operating at microwave power, 
10 mW; microwave frequency, 9.08 CHz; and 
modulation amplitude, 6.3 G. Elution patterns 
were obtained with a 1 mm cell on a Uvicord-S 
(LKB) operating at 253 nm. 
We used BAPN (,&aminopropionitrile 
fumarate), DTNB (5,5’-dithiobis-2-nitrobenzoic 
acid), p-CMB @chloromercuribenzoate) and ben- 
zylamine hydrochloride from Sigma. The latter 
was additionally purified by recrystallization from 
ethanol immediately before use. Sepharose 4B and 
Sephadex G-200 were from Pharmacia and po- 
ly(ethylene glycol) (PEG) of I@ 2000 from Loba- 
Chemie. The concentrating of the enzyme was car- 
ried out using ultrafiltration through Millipore 
type PSAC membranes. 
3. RESULTS AND DISCUSSION 
3.1. Isolation of benzylamine oxidase from 
microvessels 
One g of microvessels was suspended in 4 ml of 
0.2 M phosphate buffer (pH 7.7) and homogeniz- 
ed in a hand-held homogenizer for 5-10 min. The 
residue obtained after centrifugation at 15 000 x g 
for 15 min was again homogenized with a new por- 
tion of the buffer. Supernatants of both cen- 
trifugations were combined and solid PEG was 
added to a final concentration of 24%. The residue 
formed after 30 min incubation of the mixture at 
5°C was collected by centrifugation (15 000 x g, 
30 min) and dissolved in 200 ml of 0.2 M 
phosphate buffer (pH 7.7). This solution was then 
gel filtered through Sepharose 4B. Fractions with 
benzylamine oxidase activity were collected, con- 
centrated by ultrafiltration, and gel filtration 
through Sepharose 4B was repeated. Fig.1 shows 
elution patterns obtained during two gel-filtration 
procedures. In table 1 the protocol of the typical 
purification procedure of benzylamine oxidase 
from cerebral cortex microvessels is presented. As 
can be seen, more than 400-fold purification of the 
enzyme was achieved with high yield. The final 
preparation was found to have a specific activity of 
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Fig. 1. The typical elution patterns obtained in the course 
of purification of benzylamine oxidase through first (A) 
and second (B) columns with Sepharose 4B. For both gel 
filtrations the same column (1.2 x 56) was used. 
about 200 units. When yields of the enzyme from 
brain microvessels and heart aorta [7] were com- 
pared it was noted that microvessels were 
significantly richer (by a factor 10) in this enzyme 
than large vessels. This probably reflects the lesser 
content of collagenous proteins in the microvessels 
as compared with large vessels. 
3.2. Properties of the enzyme from microvessels 
The M, of the enzyme determined by gel filtra- 
tion in 0.04 M phosphate buffer (pH 7.7) was 
found to be 800000. Assays of the copper content 
in the enzyme by EPR and chemical methods led to 
a value of 1 copper atom per 60000 Da. Thus, the 
enzyme from microvessels is a multicopper protein 
consisting of many subunits. A similar conclusion 
was drawn for benzylamine oxidase from bovine 
Table 1 
Basic steps of the purification of benzylamine oxidase 
from brain microvessels 
Step Total 
protein 
(mg) 
Specific 
activity 
Homogenate of microvessels 
PEG fractionation 
Second gel filtration through 
Sepharose 4B 
0.5 
40 30 
5 200-210 
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heart aorta [7]. On the other hand, the M* of ben- 
zylamine oxidase from large blood vessels and 
microvessels was significantly higher than that of 
blood plasma [HI. 
Results of kinetic studies of benzyIamine oxida- 
tion by the enzyme are shown in fig.2. We found 
further that BAPN, which is known to be an effec- 
tive inhibitor of benzylamine oxidase and lysyl ox- 
idase of aorta [3], also inhibits benzylamine ox- 
idase of brain microvessels. Optical and EPR spec- 
tra of benzylamine oxidase of brain microvessels 
are presented in fig.3. It should be noted that no 
band was present in the visible region of the optical 
spectrum. As can be seen, the optical spectrum in 
the UV region of the enzyme is very specific. Pro- 
teins rarely have a UV spectrum of this type. 
Besides benzylamine oxidase from aorta 171, the 
same spectrum has been observed for metallothio- 
nein, a small protein Iacking aromatic amino acids 
but very rich in cysteines [161. In this connection it 
is of importance to note that the content of thiol 
groups in benzylamine oxidase was significantly 
lower than that of metallothionein. Thus, only 3-4 
groups per 60000 Da were found for the enzyme 
from microvessels whereas in typical metallothio- 
neins there are more than 20 cysteine residues per 
molecule of 7000 Da f163. Benzylamine oxidase 
Fig.2. Reciprocal plot for benzylamine oxidation by the 
enzyme from brain microvessels. The dotted line 
indicates the region of substrate concentration where 
inhibition by the substrate was observed. 
Fig.3. Optical {above) and EPR (below) spectra of the 
native preparation of benzylamine oxidase from 
microvessels taken at pH 7.4 (phosphate buffer). 
from microvessels hould be considered as a thiol- 
dependent enzyme because thiol reagents such as 
p-CMB and DTNB inhibit the activity of the 
enzyme. 
EPR spectral parameters of the enzyme, in par- 
ticular the value of Ali = 150 G, show that this en- 
zyme should be referred to the class of so-called 
‘non-blue’ copper-containing oxidases. We found 
further, in accordance with previous data on ben- 
zylamine oxidase from aorta, that in the presence 
of cyanide or BAPN the EPR signal of Cu2+ disap- 
pears. This phenomenon has also been observed 
with other copper-containing proteins [ 171. Thus, 
there are many analogies, if not identity, between 
benzylamine oxidases from large and small blood 
vessels, however the content of the enzyme in small 
vessels appears to be higher than in large vessels. 
91 
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